Cytogenetic and molecular genetic aspects of eosinophilic leukaemias

[11] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) : 1201 - 1214

[12] Cortes JE, 2002, BLOOD, V100, p71A

[13] A MYELOPROLIFERATIVE DISEASE IN 2 INFANTS ASSOCIATED WITH EOSINOPHILIA AND CHROMOSOME-T(1-5) TRANSLOCATION [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (04) : 483 - 486

[14] EVIDENCE FOR THE CLONAL NATURE OF HYPEREOSINOPHILIC SYNDROME [J]. CANCER GENETICS AND CYTOGENETICS, 1988, 32 (01) : 109 - 115

[15] Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32) [J]. CANCER GENETICS AND CYTOGENETICS, 1997, 94 (02) : 91 - 94

[16] ELLMAN L, 1979, CANCER-AM CANCER SOC, V43, P2410, DOI 10.1002/1097-0142(197906)43:6<2410::AID-CNCR2820430636>3.0.CO

[17] 2-I

[18] Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder:: The first fusion gene involving BCR but not ABL [J]. GENES CHROMOSOMES & CANCER, 2001, 32 (04) : 302 - 310

[19] Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7): Confirmation of eosinophil clonal involvement by fluorescence in situ hybridization [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 107 (01) : 65 - 68

[20] Treatment of hypereosinophilic syndrome with imatinib mesilate [J]. LANCET, 2002, 359 (9317) : 1577 - 1578

[11] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) : 1201 - 1214

[12] Cortes JE, 2002, BLOOD, V100, p71A

[13] A MYELOPROLIFERATIVE DISEASE IN 2 INFANTS ASSOCIATED WITH EOSINOPHILIA AND CHROMOSOME-T(1-5) TRANSLOCATION [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (04) : 483 - 486

[14] EVIDENCE FOR THE CLONAL NATURE OF HYPEREOSINOPHILIC SYNDROME [J]. CANCER GENETICS AND CYTOGENETICS, 1988, 32 (01) : 109 - 115

[15] Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32) [J]. CANCER GENETICS AND CYTOGENETICS, 1997, 94 (02) : 91 - 94

[16] ELLMAN L, 1979, CANCER-AM CANCER SOC, V43, P2410, DOI 10.1002/1097-0142(197906)43:6<2410::AID-CNCR2820430636>3.0.CO

[17] 2-I

[18] Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder:: The first fusion gene involving BCR but not ABL [J]. GENES CHROMOSOMES & CANCER, 2001, 32 (04) : 302 - 310

[19] Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7): Confirmation of eosinophil clonal involvement by fluorescence in situ hybridization [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 107 (01) : 65 - 68

[20] Treatment of hypereosinophilic syndrome with imatinib mesilate [J]. LANCET, 2002, 359 (9317) : 1577 - 1578